Skandinaviska Enskilda Banken AB (publ)
Position in KALV — KalVista Pharmaceuticals, Inc.
CIK 1534653
STOCKHOLM, V7
Position in KALV
as of Dec 31, 2025
· filed Feb 12, 2026
Position Value
$5,673,575
+$3,225,505 QoQ
Shares Held
351,305
+74.8% QoQ
Ownership
0.660%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Skandinaviska Enskilda Banken AB (publ) holds $26,512,520 across 3 Biotechnology names.
All Filings in KALV
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $5,673,575 | 351,305 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $2,448,070 | 200,991 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $461,956 | 40,863 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $471,559 | 40,863 | Shares | Defined | 2025-05-07 | |
| 2024-12-31 | $346,109 | 40,863 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $473,193 | 40,863 | Shares | Defined | 2024-11-07 | |
| 2024-06-30 | $481,366 | 40,863 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $484,635 | 40,863 | Shares | Defined | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||